Antibiotic Resistance Pattern of Pathogens Isolated from Pediatric Patients during and after the COVID-19 Pandemic
<b>Background/Objectives</b>: The present study aims to highlight the possible significant changes due to the COVID-19 pandemic in the resistance of pathogens involved in cases of pediatric infections. <b>Methods</b>: This study included children hospitalized in the Pediatric Intensive Care Unit, Surgery and Pediatrics from a tertiary teaching hospital, during and after the COVID-19 period (2020-2023). <b>Results</b>: The research included 845 samples collected during 2020-2023, from 685 pediatric patients. A total of 937 bacterial isolates were obtained, of which 509 isolates (54.32%) were Gram-negative bacteria. Around 30% of all the pathogens were multidrug-resistant (MDR), with a statistically significant increase post-pandemic, in the case of the MDR <i>Escherichia coli</i> strains (<i>p</i> < 0.05). A very high percentage of MDR <i>Acinetobacter</i> spp. isolates was found, with an important, but not statistically significant, increase in the post-pandemic period. The highest percentage of the MDR Gram-positive pathogens was registered in the case of <i>S. aureus</i> strains (31.80%). Over 20% of the <i>Coagulase-negative Staphylococci (CoNS)</i> strains isolated between 2020 and 2023 were MDR, with an important increase in the post-COVID-19 period. The proportion of carbapenem-resistant Gram-negative pathogens significantly decreased in the post-COVID-19 period compared with the COVID-19 period (<i>p</i> < 0.05), especially in the case of the <i>Klebsiella</i> spp. strains. <b>Conclusions</b>: Our findings revealed the increase in the post-COVID-19 period of the prevalence of MDR strains of <i>Acinetobacter</i> spp., <i>CoNS</i>, and <i>Escherichia coli</i> isolated in pediatric patient samples and a significant decline in the trend of the carbapenem-resistant Gram-negative pathogens, which may be due to the testing rate and to the specific pathology of the pediatric patients hospitalized in the two periods.
Authors
- Simona Georgiana Popa (ORCID: https://orcid.org/0000-0002-4929-2708)
- M. Cara (ORCID: https://orcid.org/0000-0002-5471-4717)
- Andreea Loredana Golli (ORCID: https://orcid.org/0000-0002-1802-3601)
- Dragoș Forțofoiu (ORCID: https://orcid.org/0009-0002-4143-844X)
- Maria Stoïca
- George-Alin Stoica
Institutions
- University of Medicine and Pharmacy of Craiova (RO)
Publication Details
- Journal
- Antibiotics
- Published
- 2024-10-13
- DOI
- https://doi.org/10.3390/antibiotics13100966
- Citations
- 3
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.89